People with diabetes may also face an increased risk of diabetes-related eye problems and low blood sugar (if taking certain diabetes drugs)
Last year, Ron Evans, professor and director of the Gene Expression Laboratory and March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute for Biological Studies, received the award for his fundamental discovery and characterization of nuclear hormone receptors and their applications for drug development and human health
Early results from ongoing clinical studies are indicating the GLP-1 medications may successfully treat numerous other conditions including non-alcoholic fatty liver disease (known as metabolic dysfunction-associated steatohepatitis or MASH), sleep apnea, heart failure, diabetic kidney disease and Alzheimers disease
These are extraordinary numbers that no other obesity medication has matched
however, the trim-and-fill method indicated that this publication bias did not change the statistical significance of the estimate